共 39 条
- [3] Patient Preferences for Adjuvant Treatment in Muscle-Invasive Urothelial Carcinoma: A Multi-Country Discrete Choice Experiment PATIENT PREFERENCE AND ADHERENCE, 2023, 17 : 2237 - 2248
- [7] Genomic Alterations and Outcomes With Fixed-Duration Ibrutinib plus Venetoclax: Results From the Phase 3 GLOW Study in Patients With Previously Untreated Chronic Lymphocytic Leukemia (CLL) CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S329 - S329